Low Dose Ruxolitinib in Indian Haplo-Identical Transplant Patients with Steroid Refractory Acute Graft Versus Host Disease

被引：0
|
作者：
Kumar, Kishore [1 ]
Prabhu, Durai [2 ]
Kandan, Mani [3 ]
Thooran, Sen [3 ]
Subash, Chezhian [1 ]
机构：
[1] MIOT Inst Haematol, Chennai, Tamil Nadu, India
[2] MIOT Int Hosp, Chennai, Tamil Nadu, India
[3] MIOT, Chennai, Tamil Nadu, India
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157269
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12893 / 12894
页数：2
相关论文
共 50 条
  • [11] Ruxolitinib in chronic steroid-refractory graft-versus-host-disease.
    Kovalenko, Iuliia
    Saleem, Tabinda
    Laek, Babray
    Ali, Rimsha
    Mirza, Taaha Muddassir
    Chattaraj, Asmi
    Wahab, Ahsan
    Din, Asma Tamez Ud
    Qurashi, Hafiz
    Golubykh, Konstantin
    Malik, Maidah
    Khan, Rafiullah
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [12] Ruxolitinib treatment for steroid-refractory graft-versus-host disease
    Park, Han-Seung
    Lee, Je-Hwan
    Lee, Jung-Hee
    Choi, Eun-Ji
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Kyoo-Hyung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 323 - 324
  • [13] TREATMENT OF STEROID-REFRACTORY SKIN GRAFT VERSUS HOST DISEASE WITH A CD3 TCR AB / CD19-DEPLETED HAPLO-IDENTICAL HSCT
    Nademi, Z.
    Gennery, A.
    Dunn, J.
    Slatter, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S537 - S538
  • [14] Real World Outcomes of Ruxolitinib Treatment of Steroid Refractory/Dependent Acute Graft Versus Host Disease
    Leung, Becky
    Butler, Jason
    Curley, Cameron
    Henden, Andrea S.
    Hunt, Stewart
    Morton, James
    Subramoniapillai, Elango
    Stewart, Caroline
    Tey, Siok-Keen
    Kennedy, Glen A.
    Scott, Ashleigh P.
    BLOOD, 2024, 144 : 7351 - 7351
  • [15] Real-World Experience with Ruxolitinib Therapy for Steroid Refractory Acute Graft Versus Host Disease
    Murray, Alistair
    Linn, Swe Mar
    Yu, Benoit
    Novitzky-Basso, Igor
    Mattsson, Jonas
    Elemary, Mohamed
    White, Jennifer
    Lemieux, Christopher
    Jamani, Kareem
    Kim, Dennis
    BLOOD, 2022, 140 : 7662 - 7663
  • [16] SINGLE PEDIATRIC CENTER EXPERIENCE OF USING ABATACEPT FOR GRAFT-VERSUS-HOST-DISEASE PROPHYLAXIS IN HAPLO-IDENTICAL HEMATOPOIETIC CELL TRANSPLANT
    Raffa, Enass
    Wall, Donna A.
    Schechter, Tal
    Ali, Muhammad
    Krueger, Joerg
    Srinivasan, Anand
    Chiang, K. Y.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S202 - S202
  • [17] Early Outcomes of Ruxolitinib in the Treatment of Steroid Refractory Graft-versus-host Disease on Liver Transplant Recipients
    Kakadia, Sunilkumar
    Trotta, Holly
    Kurczek, Leslie
    Burdine, Lyle
    Veeraputhiran, Muthu
    Giorgakis, Emmanouil
    TRANSPLANTATION, 2020, 104 (08) : E247 - E247
  • [18] Efficacy of Etanercept in patients with steroid refractory acute graft versus host disease
    Ma, Chun Kei Kris
    Garcia-Cadenas, Irene
    Fox, Laura
    Ai, Sylvia
    Nivison-Smith, Ian
    Milliken, Samuel Thomas
    Dodds, Anthony
    Fay, Keith
    Ma, David D. F.
    Martino, Rodrigo
    Sierra, Jorge
    Moore, John
    BONE MARROW TRANSPLANTATION, 2018, 53 : 412 - 413
  • [19] Use of Ruxolitinib in Pediatric Patients with Steroid-Refractory Graft-versus-host Disease (GVHD)
    Becilli, Marco
    Merli, Pietro
    Pagliara, Daria
    Galaverna, Federica
    Algeri, Mattia
    Gaspari, Stefania
    Boccieri, Emilia
    Carta, Roberto
    Ruggeri, Annalisa
    Locatelli, Franco
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 631 - 631
  • [20] Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease
    Belina, Morgan E.
    Driscoll, Timothy A.
    Blanchard, Sarah K.
    Cardones, Adela R.
    PEDIATRIC DERMATOLOGY, 2022, 39 (03) : 432 - 433
12345